Fudan University Shanghai Cancer Center

Fudan University Shanghai Cancer Center Breakthrough Discovery: “Metabolic Waste” Offers New Hope for Immunotherapy in "King of Cancers"

Recently, the research team led by Professor Xianjun Yu and Doctor Si Shi from Fudan University Shanghai Cancer Center published a groundbreaking study revealing that lactate, traditionally regarded as a “metabolic waste,”
Nature | Xu Yanhui team uncovers the dynamics of RNA polymerase III transcription initiation

RNA polymerases (RNAPs) are the core enzymes of transcription, responsible for transcribing genetic information from DNA into RNA. In mammalian nuclei, RNAPs have evolved into three functionally distinct forms...
Voice of China at ESSO | FUSCC was invited to the international stage, showcasing the wisdom and elegance of Chinese colorectal oncologists

From October 2nd to 4th, 2024, the 43rd Congress of the European Society of Surgical Oncology (ESSO) was held in Antwerp, Belgium.
Chinese prostate cancer drug shows promising results

A multi-center research project consisting of 72 top urinary cancer centers in China and abroad confirmed that a Chinese-developed prostate cancer drug can reduce mortality rates by 42 percent and reduce the risk of other cancerous developments by 56 perc
The researches from Fudan University Shanghai Cancer Center mapped the proteogenomic profile of clear cell renal cell carcinoma

China is a country with the large number of kidney cancer, and about 40% of patients are diagnosed with metastatic renal cancer or occure distant metastasis during disease follow-up, which leads to poor treatment outcomes. High genetic heterogeneity and

Fudan University Shanghai Cancer Center Breakthrough Discovery: “Metabolic Waste” Offers New Hope for Immunotherapy in "King of Cancers"

Nature | Xu Yanhui team uncovers the dynamics of RNA polymerase III transcription initiation

Voice of China at ESSO | FUSCC was invited to the international stage, showcasing the wisdom and elegance of Chinese colorectal oncologists

Chinese prostate cancer drug shows promising results

The researches from Fudan University Shanghai Cancer Center mapped the proteogenomic profile of clear cell renal cell carcinoma

NEWS

Notice Board

LINKS